An association between atherosclerosis and venous thrombosis

New England Journal of Medicine

Volumn 348, Issue 15, 2003, Pages 1435-1441

  Prandoni, Paolo ^a   Bilora, Franca ^a   Marchiori, Antonio ^a   Bernardi, Enrico ^a   Petrobelli, Francesco ^a   Lensing, Anthonie W A ^b   Prins, Martin H ^c   Girolami, Antonio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CAROTID ARTERY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM; VEIN THROMBOSIS;

AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0037431022     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa022157     Document Type: Article

References (47)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates ofdeep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991;151:933-8.
2. Nordström M, Lindbläd B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
3. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population: 'the Study of Men Born in 1913.' Arch Intern Med 1997;157:1665-70.
4. Silverstein MD, Heit JA, Molar DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93.
5. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. Thromb Haemost 2000;83:657-60.
6. Prandoni P, ten Cate JW. Epidemiology, risk factors, and natural history of venous thromboembolism. In: Oudkerk M, van Beek EJR, ten Cate JW, eds. Pulmonary embolism. Berlin, Germany: Blackwell Science, 1999:2-32.
7. Kearon C, Salzman EW, Hirsh J. Epidemiology, pathogenesis, and natural history of venous thrombosis. In: Colman KW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and thrombosis: basic principles & clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:1153-78.
8. Heit J. Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost 2002;28:Suppl 2:3-13.
9. Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med 2001;135:367-73.
10. Lensing AWA, Prandoni P, Prins MH, Büller HR. Deep-vein thrombosis. Lancet 1999;353:479-85.
11. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course ofacute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
12. Prandoni P, Lensing AWA, Büller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992;327:1128-33.
13. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994;154:164-8.
14. Libertiny G, Hands L. Deep venous thrombosis in peripheral vascular disease. Br J Surg 1999;86:907-10.
15. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997;277:642-5.
16. Vaya A, Mira Y, Ferrando F, et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol 2002;118:255-9.
17. Libby P, Simon DI. Thrombosis and atherosclerosis. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and thrombosis: basic principles & clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:743-52.
18. Libby P. Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin Cardiol 2000;23:Suppl 6:VI-3-VI-7.
19. Sueishi K, Ichikawa K, Kato K, Nakagawa K, Chen YX. Atherosclerosis: coagulation and fibrinolysis. Semin Thromb Hemost 1998;24:255-60.
20. Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997;8:320-8.
21. FitzGerald GA, Tigges J, Barry P, Lawson JA. Markers of platelet activation and oxidant stress in atherothrombotic disease. Thromb Haemost 1997;78:280-4.
22. Drouet L, Mazoyer E, Bal dit Sollier C, Hainaud P, Ripoll L. Participation des mécanismes de la thrombose et de l'hémostase aux étapes initiales de l'athérosclérose. Arch Mal Coeur Vaiss 1998;91(Special V):41-51.
23. Koenig W, Kothenbacher Rothenbacher D, Hoffineister A, Griesshammer M, Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Arterioscler Thromb Vasc Biol 2001;21:1701-5.
24. Eikelboom BC. The prevalence of asymptomatic carotid artery disease. In: Bernstein EF, Callow AD, Nicolaides AN, Shifrin EG, eds. Cerebral revascularisation. London: Med-Orion, 1993:451-6.
25. Joakimsen O, Bonaa KH, Stensland-Bugge E, Jacobsen BK. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: the Tromso Study. Arterioscler Thromb Vasc Biol 1999;19:3007-13.
26. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841-50.
27. Binaghi F, Fronteddu PF, Putzu V, Cannas F, Pitzus F. Associazione tra lesioni carotidee valuate mediante eco color-Doppler efattori di rischio cardiovascolari in una casistica di soggetti in età geriatrica. Minerva Cardioangiol 1998;46:217-27.
28. Hollander M, Bots ML, Del Sol AI, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 2002;105:2872-7.
29. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999;81:198-202.
30. 506→Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 1997;336:399-403.
31. Simioni P, Prandoni P, Lensing AWA, et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000;96:3329-33.
32. Simioni P, Prandoni P, Burlina A, et al. Hyperhomocysteinemia and deep-vein thrombosis: a case-control study. Thromb Haemost 1996;76:883-6.
33. Simioni P, Prandoni P, Zanon E, et al. Deep venous thrombosis and lupus anticoagulant: a case-control study. Thromb Haemost 1996;76:187-9.
34. Tierney LM Jr, McPhee SJ, Papadakis MA, eds. Current medical diagnosis & treatment. 39th ed. New York: Lange Medical Books/McGraw-Hill, 2000.
35. Bernstein EF. Current noninvasive evaluation of extracranial arterial disease. In: Bernstein EF, Callow AD, Nicolaides AN, Shifrin EG, eds. Cerebral revascularisation. London: Med-Orion, 1993:73-83.
36. Zierler RE. Real-time color flow Doppler carotid imaging. In: Bernstein EF, ed. Vascular diagnosis. 4th ed. St. Louis: Mosby, 1993:328-32.
37. Andreescu ACM, Cushman M, Rosendaal FR. D-Dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Thromb Haemost 2002;87:47-51.
38. Prins MH, Hirsh J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. Arch Intern Med 1991;151:1721-31.
39. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002;87:7-12.
40. Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001;161:1405-10.
41. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 2000;132:689-96.
42. Ray JG, Rosendaal FR, The role of dyslipidemia and statins in venous thromboembolism. Curr Control Trials Cardiovasc Med 2001;2:165-70.
43. Foley PW, Irvine CD, Standen GR, et al. Activated protein C resistance, factor V Leiden and peripheral vascular disease. Cardiovasc Surg 1997;5:157-60.
44. Gaustadnes M, Rudiger N, Moller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999;10:251-9.
45. Marder VJ, Matei DE. Hereditary and acquired thrombophilic syndromes. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and thrombosis: basic principles & clinical practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:1243-76.
46. Triplett DA. Risk factors for coronary artery disease. Hemostasis News 2001;6:1-5.
47. Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants ofcarotid atherosclerosis in a general population. Stroke 1992;23:1705-11.